FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283325073> ?p ?o ?g. }

• W4283325073 endingPage "1389" @default.
• W4283325073 startingPage "1378" @default.
• W4283325073 abstract "Minimal residual disease (MRD) analysis is a known predictive tool in mantle cell lymphoma (MCL). We describe MRD results from the Fondazione Italiana Linfomi phase 3 MCL0208 prospective clinical trial assessing lenalidomide (LEN) maintenance vs observation after autologous stem cell transplantation (ASCT) in the first prospective comprehensive analysis of different techniques, molecular markers, and tissues (peripheral blood [PB] and bone marrow [BM]), taken at well-defined time points. Among the 300 patients enrolled, a molecular marker was identified in 250 (83%), allowing us to analyze 234 patients and 4351 analytical findings from 10 time points. ASCT induced high rates of molecular remission (91% in PB and 83% in BM, by quantitative real-time polymerase chain reaction [RQ-PCR]). Nevertheless, the number of patients with persistent clinical and molecular remission decreased over time in both arms (up to 30% after 36 months). MRD predicted early progression and long-term outcome, particularly from 6 months after ASCT (6-month time to progression [TTP] hazard ratio [HR], 3.83; P < .001). In single-timepoint analysis, BM outperformed PB, and RQ-PCR was more reliable, while nested PCR appeared applicable to a larger number of patients (234 vs 176). To improve MRD performance, we developed a time-varying kinetic model based on regularly updated MRD results and the MIPI (Mantle Cell Lymphoma International Prognostic Index), showing an area under the ROC (Receiver Operating Characteristic) curve (AUROC) of up to 0.87 using BM. Most notably, PB reached an AUROC of up to 0.81; with kinetic analysis, it was comparable to BM in performance. MRD is a powerful predictor over the entire natural history of MCL and is suitable for models with a continuous adaptation of patient risk. The study can be found in EudraCT N. 2009-012807-25 (https://eudract.ema.europa.eu/)." @default.
• W4283325073 created "2022-06-24" @default.
• W4283325073 creator A5005592897 @default.
• W4283325073 creator A5012645361 @default.
• W4283325073 creator A5020789491 @default.
• W4283325073 creator A5034220119 @default.
• W4283325073 creator A5042513487 @default.
• W4283325073 creator A5046418969 @default.
• W4283325073 creator A5051021130 @default.
• W4283325073 creator A5051195250 @default.
• W4283325073 creator A5053891408 @default.
• W4283325073 creator A5056141793 @default.
• W4283325073 creator A5057806356 @default.
• W4283325073 creator A5060801603 @default.
• W4283325073 creator A5069053301 @default.
• W4283325073 creator A5071466957 @default.
• W4283325073 creator A5072006834 @default.
• W4283325073 creator A5073971614 @default.
• W4283325073 creator A5074069337 @default.
• W4283325073 creator A5075650555 @default.
• W4283325073 creator A5076353357 @default.
• W4283325073 creator A5077431006 @default.
• W4283325073 creator A5078865689 @default.
• W4283325073 creator A5079136601 @default.
• W4283325073 creator A5083791979 @default.
• W4283325073 creator A5085365536 @default.
• W4283325073 creator A5088788871 @default.
• W4283325073 creator A5089025495 @default.
• W4283325073 date "2022-09-22" @default.
• W4283325073 modified "2023-10-05" @default.
• W4283325073 title "Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma" @default.
• W4283325073 cites W13575375 @default.
• W4283325073 cites W1486753210 @default.
• W4283325073 cites W1543389126 @default.
• W4283325073 cites W1580687288 @default.
• W4283325073 cites W1977632364 @default.
• W4283325073 cites W2012232903 @default.
• W4283325073 cites W2019612632 @default.
• W4283325073 cites W2019633460 @default.
• W4283325073 cites W2029511375 @default.
• W4283325073 cites W2038414910 @default.
• W4283325073 cites W2052415602 @default.
• W4283325073 cites W2055043387 @default.
• W4283325073 cites W2065464657 @default.
• W4283325073 cites W2068909560 @default.
• W4283325073 cites W2069085828 @default.
• W4283325073 cites W2109242212 @default.
• W4283325073 cites W2158686006 @default.
• W4283325073 cites W2160957972 @default.
• W4283325073 cites W2430862255 @default.
• W4283325073 cites W2558507146 @default.
• W4283325073 cites W2565192467 @default.
• W4283325073 cites W2760635695 @default.
• W4283325073 cites W2773584979 @default.
• W4283325073 cites W2888274876 @default.
• W4283325073 cites W2889531115 @default.
• W4283325073 cites W3016696556 @default.
• W4283325073 cites W3047074915 @default.
• W4283325073 cites W3087400259 @default.
• W4283325073 cites W3095333026 @default.
• W4283325073 cites W3096166445 @default.
• W4283325073 cites W3116598306 @default.
• W4283325073 cites W3117664287 @default.
• W4283325073 cites W3138347145 @default.
• W4283325073 cites W3160275000 @default.
• W4283325073 cites W3211725115 @default.
• W4283325073 cites W4252949489 @default.
• W4283325073 cites W4256005235 @default.
• W4283325073 doi "https://doi.org/10.1182/blood.2021014270" @default.
• W4283325073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35737911" @default.
• W4283325073 hasPublicationYear "2022" @default.
• W4283325073 type Work @default.
• W4283325073 citedByCount "9" @default.
• W4283325073 countsByYear W42833250732022 @default.
• W4283325073 countsByYear W42833250732023 @default.
• W4283325073 crossrefType "journal-article" @default.
• W4283325073 hasAuthorship W4283325073A5005592897 @default.
• W4283325073 hasAuthorship W4283325073A5012645361 @default.
• W4283325073 hasAuthorship W4283325073A5020789491 @default.
• W4283325073 hasAuthorship W4283325073A5034220119 @default.
• W4283325073 hasAuthorship W4283325073A5042513487 @default.
• W4283325073 hasAuthorship W4283325073A5046418969 @default.
• W4283325073 hasAuthorship W4283325073A5051021130 @default.
• W4283325073 hasAuthorship W4283325073A5051195250 @default.
• W4283325073 hasAuthorship W4283325073A5053891408 @default.
• W4283325073 hasAuthorship W4283325073A5056141793 @default.
• W4283325073 hasAuthorship W4283325073A5057806356 @default.
• W4283325073 hasAuthorship W4283325073A5060801603 @default.
• W4283325073 hasAuthorship W4283325073A5069053301 @default.
• W4283325073 hasAuthorship W4283325073A5071466957 @default.
• W4283325073 hasAuthorship W4283325073A5072006834 @default.
• W4283325073 hasAuthorship W4283325073A5073971614 @default.
• W4283325073 hasAuthorship W4283325073A5074069337 @default.
• W4283325073 hasAuthorship W4283325073A5075650555 @default.
• W4283325073 hasAuthorship W4283325073A5076353357 @default.
• W4283325073 hasAuthorship W4283325073A5077431006 @default.
• W4283325073 hasAuthorship W4283325073A5078865689 @default.
• W4283325073 hasAuthorship W4283325073A5079136601 @default.

• next